APOE epsilon3 gene transfer attenuates brain damage after experimental stroke

Barry W McColl, Ailsa L McGregor, Andrew Wong, Julian D Harris, Andrea Amalfitano, Sandra Magnoni, Andrew H Baker, George Dickson, Karen Horsburgh

Research output: Contribution to journalArticlepeer-review


Apolipoprotein E (apoE, protein; APOE, gene) is the major lipid-transport protein in the brain and plays an important role in modulating the outcome and regenerative processes after acute brain injury. The aim of the present study was to determine if gene transfer of the epsilon3 form of APOE improves outcome in a murine model of transient focal cerebral ischaemia. Mice received an intrastriatal injection of vehicle, a second-generation adenoviral vector containing the green fluorescent protein gene (Ad-GFP) or a vector containing the APOE epsilon3 gene (Ad-APOE) 3 days before 60 mins focal ischaemia. Green fluorescent protein expression was observed in cells throughout the striatum and subcortical white matter indicating successful gene transfer and expression. ApoE levels in the brain were significantly increased after Ad-APOE compared with Ad-GFP or vehicle treatment. Ad-APOE treatment reduced the volume of ischaemic damage by 50% compared with Ad-GFP or vehicle treatment (13+/-3 versus 29+/-4 versus 27+/-5 mm(3)). The extent of postischaemic apoE immunoreactivity was enhanced in Ad-APOE compared with Ad-GFP or vehicle treated mice. These results show the ability of APOE gene transfer to markedly improve outcome after cerebral ischaemia and suggest that modulating apoE levels may be a potential strategy in human stroke therapy.
Original languageEnglish
Pages (from-to)477-87
Number of pages11
JournalJournal of Cerebral Blood Flow and Metabolism
Issue number3
Publication statusPublished - 2007


Dive into the research topics of 'APOE epsilon3 gene transfer attenuates brain damage after experimental stroke'. Together they form a unique fingerprint.

Cite this